Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

mNGS -Guided Antimicrobial Treatment Versus Conventional Antimicrobial Treatment in Early Severe Community-Acquired Pneumonia Among Immunocompromised Patients

NCT05290454 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT05290454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05290454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
mNGS -Guided Antimicrobial Treatment Versus Conventional Antimicrobial Treatment in Early Severe Community-Acquired Pneumonia Among Immunocompromised Patients
Lead sponsor
Qilu Hospital of Shandong University
Phase
Not applicable
Overall status
Unknown status
Start date
August 19, 2022
Completion date
September 1, 2024
Enrollment
342 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

community-acquired pneumonia, infections, pneumonia, respiratory tract infections, severe acute respiratory infection